Clarified Number of Isolated Tumor Cells in the Uterine Sarcoma Resection template which affects the accreditation date.Lymphovascular Invasion was changed from an optional to a core element in the Breast Invasive Resection template which affects the accreditation date.Deprecated the Distance from Tumor to Vascular, Ureteral, and Soft Tissue Margin Questions for Wilms Tumor Resection: this change affects the accreditation date.All Pediatric Biopsy and Resection Protocols have an added question for Expert Consultation for Wilms Tumor resection, this change affects the accreditation date.NEW Protocol – Phyllodes Tumor of the Breast.Highlights of these content changes include: Provide your feedback about the CAP cancer protocols to College of American Pathologists March 2022 release updated 19 CAP Cancer Protocols. Changed the HER2 ISH question to conditional from optional, changed the Ki-67 question to core from optional, and deprecated the Multiparametric Gene Expression question in the Breast Biomarker templateĪll changes are outlined in the Summary of Revisions.Updated pN0 staging classification in the Breast Phyllodes template.Updated the pN3a staging classification in the Breast Invasive template.Changed Distance from Invasive Carcinoma to Closest Margin from optional to core in the Lung template.Deprecated Hepatoblastoma from the Histologic Type answers in the Hepatocellular Carcinoma template.Deleted Tumor Modifier question and combined answer list with TNM Descriptors question for the Endometrium template.Added answers under Histologic Type to include Squamous Cell Carcinoma grading in the Major Salivary Gland template.
Anus and Appendix templates were updated to include AJCC 9th version content.Protocol for Cutaneous Squamous Cell Carcinoma of the Head and Neck.All changes are outlined in the Summary of Revisions. On June 22, 2022, the College of American Pathologists released updates to 12 CAP Cancer Protocols. This protocol is required for accreditation. The CAP released the updated cancer protocols ahead of the release of the 9th version staging system to allow organizations and laboratory information system (LIS) vendors sufficient time to make changes in their systems reflecting these updates. While these updates include American Joint Committee on Cancer (AJCC) 9th version content, pathologists may continue to use the previous AJCC 8th version tumor stage classification system for cancer reporting until the updated content is required for use on January 1, 2023. June 2022 CAP Cancer Protocol Update: Clarifications
0 kommentar(er)
